参考文献
1: Baska F, Székely ER, Szántai-Kis C, Bánhegyi P, Hegymegi-Barakonyi B, Németh G, Breza N, Zsákai L, Greff Z, Pató J, Kéri G, Orfi L. [Development and study of structure-activity relationship of drugs against Mycobacterium tuberculosis]. Acta Pharm Hung. 2013;83(3):88-95. Hungarian. PubMed PMID: 24369587.
2: Santhi N, Aishwarya S. Insights from the molecular docking of withanolide derivatives to the target protein PknG from Mycobacterium tuberculosis. Bioinformation. 2011;7(1):1-4. Epub 2011 Aug 20. PubMed PMID: 21904430; PubMed Central PMCID: PMC3169209.
3: Székely R, Wáczek F, Szabadkai I, Németh G, Hegymegi-Barakonyi B, Eros D, Szokol B, Pató J, Hafenbradl D, Satchell J, Saint-Joanis B, Cole ST, Orfi L, Klebl BM, Kéri G. A novel drug discovery concept for tuberculosis: inhibition of bacterial and host cell signalling. Immunol Lett. 2008 Mar 15;116(2):225-31. doi: 10.1016/j.imlet.2007.12.005. Epub 2008 Jan 8. PubMed PMID: 18258308.
4: Scherr N, Honnappa S, Kunz G, Mueller P, Jayachandran R, Winkler F, Pieters J, Steinmetz MO. Structural basis for the specific inhibition of protein kinase G, a virulence factor of Mycobacterium tuberculosis. Proc Natl Acad Sci U S A. 2007 Jul 17;104(29):12151-6. Epub 2007 Jul 6. Erratum in: Proc Natl Acad Sci U S A. 2007 Oct 9;104(41):16388. PubMed PMID: 17616581; PubMed Central PMCID: PMC1924570.
5: Walburger A, Koul A, Ferrari G, Nguyen L, Prescianotto-Baschong C, Huygen K, Klebl B, Thompson C, Bacher G, Pieters J. Protein kinase G from pathogenic mycobacteria promotes survival within macrophages. Science. 2004 Jun 18;304(5678):1800-4. Epub 2004 May 20. PubMed PMID: 15155913.
